Physicochemical Properties
| Molecular Formula | C33H44O17 |
| Molecular Weight | 712.6923 |
| Exact Mass | 712.257 |
| CAS # | 136997-64-3 |
| Appearance | White to yellow solid powder |
| Density | 1.5±0.1 g/cm3 |
| Boiling Point | 935.3±65.0 °C at 760 mmHg |
| Flash Point | 519.5±34.3 °C |
| Vapour Pressure | 0.0±0.3 mmHg at 25°C |
| Index of Refraction | 1.653 |
| LogP | -0.25 |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| References |
[1]. Lignan glycosides from bark of Albizzia myriophylla. Phytochemistry. 1994 Nov;37(5):1455-8. |
| Additional Infomation |
(-)-Syringaresinol 4-O-β-D-apiofuranosyl-(1→2)-β-D-glucopyranoside is a lignan glycoside isolated from the bark of the plant Albizzia myriophylla. It was identified as Compound 1 in the study.[1] The molecular formula was determined to be C33H44O17 based on high-resolution FAB-mass spectrometry (negative ion mode, [M-H]- peak at m/z 711.2496).[1] Its structure was confirmed by comparison of its 13C NMR spectral data with those of a previously identified compound from another Albizzia species.[1] Enzymatic hydrolysis of this compound using crude hesperidinase yielded the aglycone, which was identified as (-)-syringaresinol based on optical rotation and 13C NMR data.[1] The study was part of a search for sweet-tasting principles from A. myriophylla, but this compound was not sweet.[1] |
Solubility Data
| Solubility (In Vitro) | DMSO : ~100 mg/mL (~140.31 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.08 mg/mL (2.92 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.08 mg/mL (2.92 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 3: ≥ 2.08 mg/mL (2.92 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 1.4031 mL | 7.0157 mL | 14.0313 mL | |
| 5 mM | 0.2806 mL | 1.4031 mL | 2.8063 mL | |
| 10 mM | 0.1403 mL | 0.7016 mL | 1.4031 mL |